Search: onr:"swepub:oai:DiVA.org:oru-65530" >
Atrial fibrillation...
Atrial fibrillation and cause of death, sex differences in mortality, and anticoagulation treatment in low-risk patients
-
- Andersson, Tommy, 1970- (author)
- Örebro universitet,Institutionen för medicinska vetenskaper
-
- Frøbert, Ole, adjungerad professor, 1964- (thesis advisor)
- Örebro universitet,Institutionen för medicinska vetenskaper
-
- Poçi, Dritan, medicine doktor, 1969- (thesis advisor)
- Örebro universitet,Institutionen för medicinska vetenskaper,Region Örebro län
-
show more...
-
- Toft, Egon, professor (opponent)
- Dean Medical College, VP Medical and Health Sciences, Qatar University, Qatar
-
show less...
-
(creator_code:org_t)
- ISBN 9789175292366
- Örebro : Örebro University, 2018
- English 71 s.
-
Series: Örebro Studies in Medicine, 1652-4063 ; 176
- Related links:
-
https://oru.diva-por... (Preview)
-
show more...
-
https://oru.diva-por...
-
https://oru.diva-por...
-
https://oru.diva-por... (primary) (Raw object)
-
https://urn.kb.se/re...
-
show less...
Abstract
Subject headings
Close
- Background: Atrial fibrillation (AF) is the most common arrhythmia but information on cause of death in patients with AF is sparse, and whether individuals at low risk of cerebral infarction (CVL) should receive antico-agulant medication is controversial. Studies of sex differences with respect to mortality risk have shown conflicting results.Methods: Data were obtained from Swedish National Registers. In Study I, there were 272 186 AF patients and matched controls and in Studies II and III, 9519 AF patients and no other diagnosis and matched controls. Study IV compared treatment with warfarin to no treatment in 48 433 patients with AF. Hazard ratio (HR) was calculated with 95% confidence intervals and outcome rates as number per 1000 person-years.Results: Ischemic heart disease (IHD) was the most common underlying cause of death and was present in 40.2% of AF patients at a HR of 1.7 (1.4-2.1). CVL/stroke was a cause of death in 13.1%, HR 2.7 (1.8-4.0). Among underlying and contributing causes of death, the most common diagnoses were IHD in 43.5%, HR 1.7 (1.4-2.0) and heart failure in 33.1%, HR 2.9 (2.2-3.7). The HRs for mortality in females with AF in age categories ≤65, 65-74, and 75-85 were 2.15, 1.72, and 1.44, and for males 1.76, 1.36, and 1.24. The rates of mortality in females with AF in age categories 55-64, 65-74, and 75-85 were 6.2, 20.7, and 57.3, and for males 8.5, 27.3, and 64.5. In patients 65-74 years, females with a CHA2DS2-VASc score of 2, and males with a score of 1 receiving warfarin treatment showed a significantly reduced risk of cerebral infarc-tion/stroke, HR 0.46 (0.25-0.83) for females and for males, HR 0.39 (0.21-0.73).Conclusions: Most common causes of death in AF patients were CVL/stroke, heart failure, and IHD. HR of mortality in patients with AF was higher in females than in males but absolute risk was higher in males with AF compared to females with AF. Anticoagulant therapy was benefi-cial in patients ≥65 years, regardless of the CHA2DS2-VASc score.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Allmänmedicin (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- General Practice (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Keyword
- Atrial fibrillation
- Cerebral infarction
- Anticoagulation
- Cause of death
- Mortality risk
- Sex differences
- CHA2DS2-VASc score
Publication and Content Type
- vet (subject category)
- dok (subject category)
Find in a library
To the university's database